Search This Blog

Thursday, May 7, 2026

Russia warns it will hit Kiev if Ukraine disrupts parade

 Russia's Defense Ministry warned in a statement on Thursday that it will launch a "massive strike" on the center of Kiev, if the Ukrainian authorities disrupt the Victory Day Parade in Moscow on May 9.

At the same time, the ministry announced a ceasefire with Ukraine from midnight on May 8 to May 10. Russian armed forces along the frontlines will abort all hostilities during this period, and all missile strikes against Ukraine will also cease. Calling on Ukraine to honor the ceasefire, the ministry nevertheless urged the civilian population of the Ukrainian capital and foreign diplomats to evacuate in a timely fashion in case of an escalation.

Ukrainian President Volodymyr Zelensky, on the other hand, accused Moscow of violating the ceasefire, stressing that his country would respond appropriately to Russian attacks.

https://breakingthenews.net/Article/Russia-warns-it-will-hit-Kiev-if-Ukraine-disrupts-parade/66245682

Trump admin may invite Nvidia, Apple CEOs on China trip

 The United States President Donald Trump administration intends to invite CEOs from Nvidia Corporation, Apple Inc., the Boeing Company, and ExxonMobil Corporation to join the president on his trip to China next week, Semafor reported on Thursday, citing a person with knowledge of the matter.

The source added that the list of executives who will be invited to accompany Trump in China also includes CEOs from Blackstone Inc., Qualcomm Inc., and Visa Inc. Other sources told the outlet that US Treasury Secretary Scott Bessent, Trade Representative Jamieson Greer, and US Ambassador to China David Perdue were in charge of making the list of attendees for the trip.

However, there are no high expectations for specific deals during the trip, and the focus will be on strengthening the relationship between Trump and China's President Xi Jinping, according to the report.

https://breakingthenews.net/Article/Trump-admin-may-invite-Nvidia-Apple-CEOs-on-China-trip/66246115

Roche shells out up to $1B for PathAI to boost AI-powered diagnostics

 Roche is set to pay out $750 million upfront to acquire digital pathology specialist Path AI in a move by the pharma giant to accelerate the use of artificial intelligence in diagnostic algorithms.

The deal, which is expected to close in the second half of this year, will see Roche make an upfront payment of $750 million for PathAI, plus additional payments of up to $300 million linked to milestone achievements.

Once the deal is locked in, PathAI will be merged into Roche’s Diagnostics division, the companies said in a May 7 release. 

The transaction will give Roche access to PathAI's Image Management System, or IMS, a user-friendly software interface that weds analysis and workflow capabilities within the digital pathology lab. Roche says it now intends to scale the platform "globally."

The Swiss pharma also figures that PathAI's established AI-driven solutions, including clinical trial support and translational research, will work well in tandem with Roche's existing companion diagnostics know-how. 

"Combining these capabilities will foster the discovery of new biomarkers, potential drug targets and novel diagnostic tools, increasing the value Roche can bring to biopharma companies," the companies said. 

The two firms first partnered in 2021 and began to ramp up their relationship in 2024 to include the development of AI-enabled companion diagnostic algorithms, they explained.

“Digital pathology has the potential to improve precision diagnosis of cancer and enable physicians to offer better tailored treatment regimens,” Matt Sause, CEO of Roche Diagnostics, said in a statement. 

The acquisition "will allow us to combine their best-in-class digital pathology tools with our leading oncology diagnosis platforms to deliver better insights for physicians and potentially better outcomes for patients worldwide," he added. 

In early December, PathAI scored an FDA first when the agency qualified its artificial intelligence tool that aids drug developers in evaluating fatty liver disease in their clinical trials.

The green light covered Path AI’s Histologic Measurement of NASH (AIM-NASH), a cloud-based technology from PathAI designed to assess disease activity for metabolic dysfunction-associated steatohepatitis (MASH). It was designed to help score the different stages of liver biopsy, including fat infiltration, inflammation and scarring.

https://www.fiercebiotech.com/medtech/roche-shell-out-1b-acquire-pathai-move-boost-ai-based-dx-algorithms

Xeris ups guidance with commercialization ramp

 

Xeris Biopharma beats Q1 2026 estimates with non-GAAP EPS $0.01 (+117% YoY), revenue $82.5M (+43% YoY), raises 2026 guidance

  • Company posts Q1 2026 profit with EPS $0.01 on $83.1M revenue, marking a return to net income
  • Raises 2026 revenue guidance to $380–$390M

Boeing Shares Rise As CEO Set To Join Trump On China Trip, Fueling Aircraft Order Speculation

 Boeing shares rose in late-morning trading in New York after CNBC reported that CEO Kelly Ortberg will join President Trump on his trip to Beijing next week for talks with President Xi Jinping.

Boeing shares climbed a little more than 2% on the news as traders began to price in the possibility of a Chinese aircraft order, potentially covering both narrow-body and wide-body jets from the U.S.-based aircraft manufacturer.

Senator Steve Daines, who is leading the bipartisan delegation to China, has called for stability and peaceful cooperation between the U.S. and China.

"I strongly believe that we want to de-escalate, not decouple. We want stability; we want mutual respect," Daines said in opening remarks at a meeting with Chinese Foreign Minister Wang Yi on Thursday, according to Reuters.

Daines also released a statement:

Readout of Daines' Congressional Delegation Trip to China

U.S. Senators Steve Daines (R-MT), Maria Cantwell (D-WA), Jerry Moran (R-KS), and Deb Fischer (R-NE) today conducted three official meetings in Beijing with Premier of China Li Qiang, Chairman of the National People's Congress Zhao Leji, and Director of the Office of the Central Foreign Affairs Commission and Foreign Minister Wang Yi.

The bipartisan delegation discussed the importance of direct and open communication between the leadership of the two countries as well as issues of international and local importance. Topics of discussion included cooperation to stop the flow of fentanyl precursors, Iran and the Strait of Hormuz, and supply chain security. The Senators discussed the importance of reciprocal trade and opening up China's markets to sustained agriculture trade across beef, wheat, pulse crops, potatoes, apples, cherries, soybeans, grain sorghum, seafood, and other industries. The delegation also discussed the importance of China's relationship with Boeing and the proposed aircraft purchase currently under consideration. The Senators expressed their hope for an impactful and successful summit between President Trump and President Xi next week.

Related:

Semafor speculates that the Trump team will invite "CEOs from Nvidia, Apple, Exxon, Boeing, and other big companies." 

Given Beijing's history of using large commercial aircraft purchases as goodwill gestures, Ortberg's inclusion on the trip raises the likelihood that Boeing could benefit and suggests tensions are cooling between the two superpowers, despite ongoing energy and trade turmoil in the Gulf region.

https://www.zerohedge.com/markets/boeing-shares-rise-ceo-set-join-trump-china-trip-fueling-aircraft-order-speculation

'Inflation Expectations Jump To 3 Year High As Financial Pessimism Surges: NY Fed Survey'

 Ahead of tomorrow's jobs report which is expected to show a substantial slowdown from last month's 178K surge, moments ago we got another reminder that the stagflationary iceberg remains front and center ahead of the US, after the NY Fed's latest monthly survey of consumer expectations reported that Inflation expectations at the one-year horizon rose again to 3.64% in April from the previous month’s 3.42%, the highest since September 2023. Inflation expectations were unchanged at 3.15% for the three-year-ahead horizon and also unchanged at 3.01% at the five-year-ahead horizon in April. 

The jump in year-ahead expectations took place even though 1 year gas inflation expectations tumbled sharply in April to 5.11% from 9.42% in April, which had been the highest reading since March 2022.

Other commodity price change expectations also rose, but to a more limited degree: food prices are now expected to rise 5.2%, down from 6%; medical costs to rise 9.6%, also a bit lower than the 9.7% in March; the price of a college education to rise 8.8% (down from 9%); and rent prices should drop from 7.1% to 6.0%.

Turning to the labor market, sentiment has continued to deteriorate fast with respondents saying that the mean probability the US unemployment rate will be higher next year rose another 0.4% (after the 3.6% jump a month ago) to 43.9%; highest reading since April 2025

On the other end, median one-year-ahead earnings growth expectations rose by 0.3% to 2.7% in March, tied for the highest since April 2025.

More bad news: the mean perceived probability of losing one’s job in the next 12 months increased again, this time by 0.2% to 14.6%, tied with the series’ 12-month trailing average of 14.6%. The mean probability of leaving one’s job voluntarily, or the expected quit rate, in the next 12 months declined by 0.1% to 18.2%.

A silver lining: the mean perceived probability of finding a job if one’s current job was increased modestly by 0.1% to 46.0%, while remaining below its 12-month trailing average of 47.5%. The increase was broad-based across age, education, and income groups.

Perceptions about households’ current financial situations also deteriorated compared to a year ago, with a larger share of households reporting a worse financial situation and a smaller share reporting a better financial situation. Year-ahead expectations about households’ financial situations also worsened, with the share of households expecting a worse financial situation at its highest level since April 2025, and a smaller share of households expecting a better financial situation in one year from now.

Perceptions of credit access compared to a year ago also deteriorated, with a higher share of households reporting it is harder to get credit and a smaller share of households reporting it is easier to get credit. Expectations for future credit availability deteriorated, with the net share of respondents expecting it will be harder to obtain credit in the year ahead increasing.

There was a glimmer of good news when it comes to household debt: the average perceived probability of missing a minimum debt payment over the next three months decreased by 0.9% to 11.4% the lowest reading in more than two years and below the 12-month trailing average of 13.2%. 

But the most concerning data was that expectations for household income dropped again, for a 5th straight months, sliding to just 2.8%, the lowest since Oct 2025...

... while spending growth expectations jumped to 5.4% - after all those inflation-adjusted prices aren't going down without a recession - the highest since July 2023.

And some more Household Finance observations:

  • The median expectation regarding a year-ahead change in taxes at current income level increased by 0.3 percentage point to 3.4%.
  • Median year-ahead expected growth in government debt increased by 0.2 percentage point to 10.0%, its highest reading since June 2023.
  • The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased to 26.7%, its highest reading since November 2024.
  • The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 2.1 percentage points to 38.4%

More in the full report from the NY Fed.

https://www.zerohedge.com/economics/inflation-expectations-jump-3-year-high-financial-pessimism-surges-ny-fed-survey


iRhythm stock rises on Medicare coverage update

 

iRhythm Holdings (IRTM) stock rises as Medicare finalizes local coverage determination for cardiac monitoring, clarifying Zio ECG coverage.

https://seekingalpha.com/news/4588747-irhythm-stock-rises-medicare-coverage-update